HTR7: A G Protein-coupled Receptor Involved in Mood, Appetite and Sleep

Target Name: HTR7

NCBI ID: G3363

HTR7

HTR7: A G Protein-coupled Receptor Involved in Mood, Appetite and Sleep

HTR7, or 5-hydroxytryptamine receptor 7, is a G protein-coupled receptor that is expressed in various tissues throughout the body. It is involved in the regulation of various physiological processes, including mood, appetite, and sleep. HTR7 has been identified as a potential drug target and is the focus of ongoing research in the field of neuropsychopharmacology.

The HTR7 receptor is a member of the 5-HT(AA) receptor family, which includes several other well-studied receptors, including 5-HT1A, 5-HT2A, 5-HT3A, and 5-HT4A. These receptors are involved in the regulation of mood, appetite, and other physiological processes that are influenced by serotonin, a neurotransmitter that plays a critical role in the regulation of mood, appetite, and other physiological processes.

HTR7 is a G protein-coupled receptor, which means that it is a protein that is involved in the regulation of a wide range of physiological processes by interacting with other proteins. G protein-coupled receptors are a family of transmembrane proteins that play a critical role in cellular signaling. They are involved in the regulation of various physiological processes, including sensory perception, neurotransmitter signaling, and cell survival.

The HTR7 receptor is a member of the 5-HT(AA) receptor family, which includes several other well-studied receptors, including 5-HT1A, 5-HT2A, 5-HT3A, and 5-HT4A. These receptors are involved in the regulation of mood, appetite, and other physiological processes that are influenced by serotonin, a neurotransmitter that plays a critical role in the regulation of mood, appetite, and other physiological processes.

HTR7 is expressed in various tissues throughout the body and is involved in the regulation of various physiological processes, including mood, appetite, and sleep. It is a potential drug target, which means that it is a target for new drugs that can be developed to treat various psychiatric and neurological disorders.

Research into the HTR7 receptor is ongoing, and several studies have identified potential drug targets for this receptor. For example, researchers have identified a number of small molecules that can interact with the HTR7 receptor and enhance its activity. These molecules have the potential to be developed into new drugs that can treat various psychiatric and neurological disorders, including depression, anxiety, and insomnia.

In addition to its potential as a drug target, HTR7 is also being studied as a biomarker for various psychiatric and neurological disorders. For example, researchers have used this receptor to measure the level of serotonin in the brain and have found that levels of serotonin are abnormal in individuals with depression and anxiety. This suggests that HTR7 may be a useful biomarker for these disorders.

Overall, the HTR7 receptor is a promising target for new drugs that can be developed to treat various psychiatric and neurological disorders. Further research is needed to fully understand the role of this receptor and to develop new treatments.

Protein Name: 5-hydroxytryptamine Receptor 7

Functions: This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that stimulate adenylate cyclase

The "HTR7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HTR7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets